PALB2 and cancer: In the same study, PALB2 was reported to have an incomplete penetrance pattern, typical of moderate cancer risk susceptibility genes, and was estimated that the relative risk for PALB2 truncating variant carriers was 2.3-fold higher than non-carriers [21].